INTRA-CELLUAR THERAPIES INCINTRA-CELLUAR THERAPIES INCINTRA-CELLUAR THERAPIES INC

INTRA-CELLUAR THERAPIES INC

No trades
See on Supercharts

ITCI fundamentals

INTRA-CELLUAR THERAPIES INC financial statements, including revenue, expenses, profit, and loss

The total revenue of ITCI for the last quarter is 2.24 B MXN, and it's 2.02% higher compared to the previous quarter. The net income of Q4 23 is -485.42 M MXN.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: MXN
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth